- Report
- May 2025
- 190 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- April 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- January 2025
- 132 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- April 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- April 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1120EUR$1,250USD£954GBP
- Report
- October 2024
- 130 Pages
Global
From €2239EUR$2,500USD£1,909GBP
- Report
- April 2025
- 100 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- April 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- March 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- March 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- April 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- March 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- June 2025
- 197 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 288 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- April 2025
- 200 Pages
Global
From €7121EUR$7,950USD£6,070GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1120EUR$1,250USD£954GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1120EUR$1,250USD£954GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1120EUR$1,250USD£954GBP

Gonadotropins are hormones that play a key role in the regulation of reproductive and sexual development. They are used to treat endocrine and metabolic disorders, such as hypogonadism, infertility, and delayed puberty. Gonadotropins are also used to induce ovulation in women with infertility.
Gonadotropin drugs are typically administered via injection, and are available in both synthetic and natural forms. Synthetic gonadotropins are typically used to treat infertility, while natural gonadotropins are used to treat hypogonadism.
The gonadotropin market is highly competitive, with a number of companies offering products for the treatment of endocrine and metabolic disorders. These companies include Merck, Ferring Pharmaceuticals, Teva Pharmaceuticals, and Ferring Pharmaceuticals. Other companies in the market include Pfizer, Novartis, and Sanofi. Show Less Read more